Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 803-807

  Zhu, Wei Guo ^a   Zhou, Ke ^a   Yu, Chang Hua ^a   Han, Ji Hua ^a   Li, Tao ^a   Chen, Xiao Fei ^a  

^a THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Esophageal carcinoma; Modulated radiotherapy; Prognosis; Simplified intensity

Indexed keywords

CISPLATIN; FLUOROURACIL;

AGED; ARTICLE; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; ESOPHAGUS TUMOR; FEMALE; HEAD AND NECK TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIATION DOSE; REMISSION; SQUAMOUS CELL CARCINOMA; THORAX TUMOR;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; THORACIC NEOPLASMS;

EID: 84867071451     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.803     Document Type: Article

References (20)

1. Chandra A, Guerrero TM, Liu HH, et al (2005). Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol, 77, 247-53.
2. Denham JW, Burmeister BH, Lamb DS, et al (1996). Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The trans tasman radiation oncology group (trog). Radiother Oncol, 40, 31-43.
3. Fenkell L, Kaminsky I, Breen S, et al (2008). Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol, 89, 287-91.
4. Fu WH, Wang LH, Zhou ZM, et al (2004). Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma. World J Gastroenterol, 10, 1098-102.
5. Geng H, Dai JR, Li YX, et al (2006). A simplified intensity modulated radiation therapy technique for difficult clinical cancer condition. Chin J Radiat Oncol, 15, 411-4.
6. Kawahara K, Maekawa T, Okabayashi K, et al (1998). The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol, 67, 160-3.
7. Korst RJ, Rusch VW, Venkatraman E, et al (1998). Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg, 115, 660-70.
8. Kurokawa T, Miyamoto M, Kato K, et al (2003). Overexpression of hypoxia-inducible-factor 1alpha (HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer,89, 1042-7.
9. Nutting CM, Bedford JL, Cosgrove VP, et al (2001). A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol, 61, 157-63.
10. Palmer MK (1982). WHO handbook for reporting results of cancer treatment. Br J Cancer, 45, 484-5.
11. Tachimori Y, Nagai Y, Kanamori N, et al (2011). Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus, 24, 33-8.
12. Tai P, Van Dyk J, Yu E, et al (2000). Radiation treatment for cervical esophagus: patterns of practice study in canada, 1996. Int J Radiat Oncol Biol Phys, 47, 703-12.
13. Tai P, Van Dyk J, Yu E, et al (1998). Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Biol Phys, 42, 277-88.
14. Trotti A, Colevas AD, Setser A, et al (2003). CTCAE v3.0, development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol, 13, 176-81.
15. Xiao ZF, Yang ZY, Liang J, et al (2003). Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg, 75, 331-6.
16. Xiao ZF, Yang ZY, Miao YJ, et al (2005). Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phy, 62, 82-90.
17. Wang SL, Liao Z, Liu H, et al (2006). Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol, 12, 5501-8.
18. Wan J, Xiao AQ, Gao SZ, et al (l989). Criteria of evaluation of immediate response of radiation therapy for esophageal carcinoma. Chin J Radiat Oncol, 3, 205-7.
19. Watarai J, Kato T, Kobayashi M, et al (1992). Locoregional control for esophageal carcinoma treated with irradiation following surgery. Tohoku J Exp Med, 168, 591-8.
20. Wu VW, Kwong DL, Sham JS (2004). Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol, 71, 201-6.